Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Luminex Q2 Revenues Rise 32 Percent on Pandemic-Related Sales

Luminex Q2 Revenues Rise 32 Percent on Pandemic-Related Sales

Aug 04, 2020
|
staff reporter

NEW YORK ─ Luminex said after the close of the market on Tuesday that its second-quarter revenues rose 32 percent year over year, driven by COVID-19-related sales, in line with preliminary revenues reported in July.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Plans Out

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

CovidNudge Numbers

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

Science Papers Propose Group to Discuss Genome-Editing Tools, Markers of Diabetes Drug Response, More

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

Not Counting These

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

What's Popular?

In Business News

  1. Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

  2. Genetics Testing Firm Prenetics Receives $15M Investment From Apis Partners, Alibaba

  3. JumpCode Genomics Emerges From Stealth Mode With CRISPR-Based Library Prep Kits

    Premium

  4. Foundation Medicine, Takeda Collaborate to Develop CDx for NSCLC Therapies

  5. CRISPR-Chip Maker Cardea Bio Raises $7.5M in First Close of Series A2 Financing Round

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.